There are an estimated 200 million cases of malaria worldwide each year, and around 600,000 deaths. But the last 15 years represent a success story in the fight against the disease: Increased investment in treatment and prevention have cut the death rate nearly in half. Now, researchers warn that resistance to the primary drug used to treat malaria is spreading. A new study has detected a resistant strain in Myanmar near the Indian border, raising concerns that resistance could soon extend its hold to sub-Saharan Africa, where more than 90 percent of malaria deaths occur. Diane and her guests discuss new concerns about combating malaria worldwide.


  • Dr. Lawrence Barat Senior technical advisor to the President's Malaria Initiative at USAID
  • Jason Beaubien Global health and development correspondent for NPR
  • Dr. Alan Magill Director of the Malaria Program at the Bill & Melinda Gates Foundation
  • Laurie Garrett Senior fellow for global health at the Council on Foreign Relations
  • Dr. William Moss Professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health; co-director of the Southern Africa International Center of Excellence for Malaria Research

Topics + Tags


comments powered by Disqus
Most Recent Shows